Antibiotics | Susceptibility and MIC | 1997–2000 (n = 19) | 2001–2003 (n = 38) | 2004–2006 (n = 24) | 2007–2009 (n = 35) | 2010–2012 (n = 28) | Total (n = 144) |
---|---|---|---|---|---|---|---|
PEN | I% | 0 | 0 | 0 | 2.9 | 0 | 0.7 |
MIC50(μg/ml) | 0.016 | 0.032 | 0.5 | 0.75 | 0.5 | 0.5 | |
MIC90(μg/ml) | 0.75 | 0.5 | 1 | 1.5 | 1 | 1 | |
MIC Range(μg/ml) | 0.004–1.5 | 0.008–0.75 | 0.012–1.5 | 0.008–3 | 0.25–1.5 | 0.004–3 | |
AMC | MIC50(μg/ml) | 0.016 | 0.023 | 0.5 | 0.5 | 0.5 | 0.38 |
MIC90(μg/ml) | 0.75 | 0.5 | 1 | 1 | 0.75 | 1 | |
MIC Range(μg/ml) | 0.008–1 | 0.008–1 | 0.016–2 | 0.008–1 | 0.25–1.5 | 0.008–2 | |
CXM | I% | 10.5 | 13.2 | 50.0 | 65.7 | 75.0 | 43.8 |
R% | 0 | 0 | 4.2 | 20.0 | 10.7 | 7.6 | |
MIC50(μg/ml) | 0.023 | 0.032 | 1.5 | 2 | 2 | 1.5 | |
MIC90(μg/ml) | 2 | 1.5 | 3 | 4 | 4 | 3 | |
MIC Range(μg/ml) | 0.016–2 | 0.008–2 | 0.016–4 | 0.032–4 | 0.25–6 | 0.008–6 | |
CRO | I% | 0 | 0 | 4.2 | 17.1 | 10.7 | 6.9 |
R% | 0 | 0 | 0 | 0 | 7.1 | 1.4 | |
MIC50(μg/ml) | 0.016 | 0.032 | 0.5 | 0.75 | 0.5 | 0.38 | |
MIC90(μg/ml) | 0.38 | 0.38 | 1 | 1.5 | 2 | 1 | |
MIC Range(μg/ml) | 0.004–0.5 | 0.008–0.75 | 0.016–1.5 | 0.008–2 | 0.25–8 | 0.004–8 | |
IPM | I% | 10.5 | 18.4 | 50.0 | 62.9 | 100 | 49.3 |
MIC50(μg/ml) | 0.012 | 0.032 | 0.094 | 0.125 | 0.19 | 0.094 | |
MIC90(μg/ml) | 0.125 | 0.125 | 0.19 | 0.19 | 0.25 | 0.19 | |
MIC Range(μg/ml) | 0.004–0.125 | 0.004–0.19 | 0.012–0.19 | 0.012–0.19 | 0.125–0.38 | 0.004–0.38 | |
TCY | I% | 0 | 5.3 | 8.3 | 40.0 | 82.1 | 28.5 |
R% | 94.7 | 86.8 | 75.0 | 28.6 | 10.7 | 56.9 | |
SXT | I% | 0 | 0 | 0 | 0 | 0 | 0 |
R% | 84.2 | 86.8 | 45.8 | 20.0 | 3.6 | 47.2 | |
CHL | R% | 52.6 | 18.4 | 20.8 | 0 | 0 | 15.3 |